Arcturus Therapeutics Holdings Inc

+0.05 (+0.33%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)410.30M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.9 Million
Adjusted EPS-$1.84
See more estimates
10-Day MA$15.61
50-Day MA$18.06
200-Day MA$17.19
See more pivots

Arcturus Therapeutics Holdings Inc Stock, NASDAQ:ARCT

10628 Science Center Drive, Suite 250, San Diego, California 92121
United States of America
Phone: +1.858.900.2660
Number of Employees: 177


Arcturus Therapeutics Holdings, Inc. develops pharmaceuticals. It is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. The firm's products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.